Targeting virus-specific CD8+ T cells for treatment of chronic viral hepatitis: from bench to bedside
{{output}}
Introduction: More than 350 million people worldwide live with chronic viral hepatitis and are thus at risk for severe complications like liver cirrhosis and hepatocellular carcinoma (HCC). To meet the goals of the World Health O... ...
